Synthesis and evaluation of 14β-acyl substituted 17-cyclopropylmethyl-7,8-dihydromorphinone derivatives: mixed partial agonists at mu opioid and nociception/orphanin FQ peptide receptors
Abstract
carbonyl in the naltrexone scaffold to methylene resulted in a balanced MOP:NOP receptor profile in this series, in particular increasing potency at the NOP receptor. Ultimately, this will allow us to determine the optimal profiles for a range of therapeutic indications including pain and drug use disorders.
Fields of Study & Subjects
Neuropeptides and Animal Physiology
Alkaloids: synthesis and pharmacology
Pain Management and Opioid Use
Publication details
- Journal / source
- RSC Medicinal Chemistry
- Volume
- 17
- Issue
- 4
- Pages
- 1950–1960
- Publication date
- 1 January 2026
- Language
- EN